Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

May 24, 2000

Baxter Pharmaceutical Products Inc. Recalls Morphine Sulfate Injection

New Providence, NJ (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Baxter Pharmaceutical Products Inc., is conducting a recall of Morphine Sulfate Injection, USP, 10 mg/mL, in 1 mL dosette(r) ampule, because of the label incorrectly declares strength as (1/8 gr per mL) not (1/6 gr per mL).

The Morphine Sulfate Injection is a prescription potent analgesic and bears the Lot Number of 099077 EXP 9/02.

FDA stated in its report that 113,750 ampuls were distributed nationwide.  The firm estimated that 3,657 ampuls remained on market at time of recall initiation.

This Class III recall was initiated by the company, by letter February 23, 2000.  This is the first public notice issued by the FDA.  The report stated that the company had completed required recall procedures.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-351-0
NDC #10019-178-68

Notice of this product warning was sent via email to SafeMail subscribers May 24, 2000.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.